Who owns PACIRA BIOSCIENCES?
- CUSIP Number: 695127af7
Tip: Access positions for across all investors
Analyze quarterly positions in Pacira Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pacira Biosciences stock
Who bought or sold PACIRA BIOSCIENCES this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wellesley Investment Advisors | 41M | $39B | -29% | Dec 2023 |
|
| Capstone Investment Advisors | 41M | $39M | 0% | Mar 2024 |
|
| Lazard Asset Management | 41M | $38M | -5% | Dec 2023 |
|
| Steelhead Partners | 37M | $35B | 24% | Mar 2024 |
|
| MacKay Shields | 36M | $34M | 0% | Mar 2024 |
|
| Tenor Capital Management | 32M | $31B | 371% | Mar 2024 |
|
| Calamos Advisors | 26M | $25M | -4% | Mar 2024 |
|
| Millennium Management | 23M | $21M | 100% | Mar 2024 |
|
| M&g Investment Management | 13M | $12M | 0% | Dec 2023 |
|
| Fort Baker Capital Management | 8.4M | $8.0M | 0% | Mar 2024 |
|
| Aequim Alternative Investments | 8.0M | $7.6M | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 6.1M | $5.7M | 104% | Mar 2024 |
|
| M&G | 5.9M | $5.6M | 100% | Mar 2024 |
|
| Palisade Capital Management | 5.5M | $5.2M | 0% | Mar 2024 |
|
| BlackRock | 2.7M | $2.5M | 0% | Mar 2024 |
|
| FMR | 2.5M | $2.4M | 100% | Mar 2024 |
|
| Bank Of Montreal | 1.0M | $948k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 746k | $707k | 100% | Mar 2024 |
|
| Credit Suisse | 600k | $550k | -45% | Mar 2024 |
|
| Bank of New York Mellon | 400k | $379k | 0% | Mar 2024 |
|
| Citigroup | 395k | $374k | 8% | Mar 2024 |
|
| Sei Investments | 299k | $283k | 0% | Mar 2024 |
|
| SSI Investment Management | 199k | $184k | -34% | Dec 2023 |
|
| Leucadia National Corporation | 155k | $148k | -74% | Mar 2024 |
|
| Cetera Investment Advisers | 145k | $137k | 100% | Mar 2024 |
|
| D.A. Davidson & Co. | 140k | $133k | 0% | Mar 2024 |
|
| Mason & Associates | 38k | $36k | 100% | Mar 2024 |
|
| Foresight Capital Management Advisors | 38k | $36k | -10% | Mar 2024 |
|
| Argent Trust | 36k | $34k | 0% | Mar 2024 |
|
| GW & Wade | 33k | $30k | 100% | Dec 2023 |
|
| SFMG Wealth Advisors | 24k | $23k | 0% | Mar 2024 |
|
| Raymond James & Associates | 22k | $21k | 100% | Mar 2024 |
|
| Kestra Advisory Services | 16k | $15k | 100% | Dec 2023 |
|
| Brian McDonald | 13k | $12k | -57% | Mar 2024 |
|
| Boston Financial Mangement | 12k | $11k | 0% | Mar 2024 |
|
| Brown Trout Management | 793.00 | $755k | 100% | Mar 2024 |
|
Who sold out of Pacira Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Opti Capital Management | Sep 2023 | 27M | $25M |
| III Capital Management | Dec 2023 | 22M | $20M |
| Linden Advisors | Sep 2023 | 21M | $19B |
| Barclays | Dec 2023 | 936k | $862k |
| Calamos Wealth Management | Dec 2023 | 135k | $125k |
| American Century Companies | Sep 2023 | 105k | $95k |
| Multi-Financial Securities | Sep 2023 | 86k | $77k |
| Financial Network Investment Corporation | Sep 2023 | 69k | $62k |
| SMI Advisory Services | Dec 2023 | 20k | $18k |
| Sonora Investment Management Group | Sep 2023 | 16k | $14k |
| Leisure Capital Management | Dec 2023 | 12k | $11k |